North America & Europe Age-related Macular Degeneration Therapeutics Market Analysis-2027

1. NORTH AMERICA & EUROPE AGE- RELATED MACULAR DEGENERATION THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION North America & Europe Age-related Macular Degeneration Therapeutics Market - Overview North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Dry AMD, and Wet AMD), By Drug Type (Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Verteporfin (Visudyne), Brolucizumab (Beovu), Supplements, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America and Europe), is estimated to be valued at US$ 9,958.7 million in 2020 and is expected to exhibit a CAGR of 6.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The increasing prevalence of age-related macular degeneration is expected to drive the market growth during the forecast period. According to the report published by the European Society of Retina Specialist, in 2017, around 34 million people in the European Union (EU) and 22 million people in the five most populous European countries (Germany, France, the U.K., Italy, and Spain) were affected by the age-related macular degeneration diseas North America & Europe Age-related Macular Degeneration Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic Small and medium ophthalmology practices have been completely shut down owing to nationwide lockdowns in key regions and only large ophthalmology practices are open which are dealing with emergency cases. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/north- america-and-europe-age-related-macular-degeneration-therapeutics-market-4171 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION However, healthcare providers are adopting telehealth solutions for cancer patients while maintain social distancing to combat COVID-19 pandemic without compromising the health of patients. Healthcare providers are encouraging patients to schedule appointments via telemedicine platforms. Browse 46 Market Data Tables and 37 Figures spread through 166 Pages and in-depth TOC on “North America & Europe Age-related Macular Degeneration Market”- North America & Europe Forecast to 2027, North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Dry AMD, and Wet AMD), By Drug Type (Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Verteporfin (Visudyne), Brolucizumab (Beovu), Supplements, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, and Europe). Market players are focusing on inorganic strategies such as collaborations, partnerships, and agreements to enhance their product portfolio and strengthen their market presence. For instance, on September 2019, Boehringer Ingelheim entered a partnership agreement (a co- development and license agreement) with Inflammasome Therapeutics Inc. for development of three therapies targeting retinal diseases including age related macular degeneration, diabetic retinopathy (DR), and diabetic macular edema (DME). Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4171 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the North America & Europe Age-related Macular Degeneration Therapeutics Market: The North America & Europe age-related macular degeneration therapeutics market is expected to exhibit a CAGR of 6.1% during the forecast period owing to launches of age-related macular degeneration therapeutics by market players. For instance, in June 2016, Intas Pharmaceuticals launched RAZUMAB, a biosimilar to Lucentis (Ranibizumab). It is indicated for treatment of Neovascular (Wet) age-related macular degeneration (AMD). Based on drug type, the Aflibercept (Eylea) segment accounted for the largest market share in 2019, owing to adoption of research and development activities by market players. For instance, in February 2020, Bayer AG and Regeneron Pharmaceuticals, Inc. announced the initiation of two phase III studies, PHOTON and PULSAR for the evaluation of extended treatment intervals with aflibercept 8mg formulation for the treatment of wet age-related macular degeneration (wet AMD). Key players operating in the North America & Europe age-related macular degeneration therapeutics market are Novartis AG, Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Pfizer, Inc., and Valeant Pharmaceuticals International, Inc. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4171 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved